Transcatheter Mitral Valve Repair and Replacement Market Size By Product, By Indication, By End User, Analysis, Growth, Opportunities And Forecast 2018 – 2026

                                                                            
Transcatheter Mitral Valve Repair and Replacement Market

Transcatheter Mitral Valve Repair and Replacement Market



The mitral valve is located between the left atrium and the left ventricle. Mitral valve illness causes the valve to malfunction, resulting in uneven blood flow. Mitral valve prolapse and regurgitation are two disorders that can result from the blood flow being unequal. Transcatheter mitral valve repair and replacement are becoming more common as a result of technological advancements in valve therapy. Mitral valve stenosis, prolapse, and regurgitation can all be addressed with transcatheter mitral valve replacement, which is a less invasive procedure than open-heart surgery.


The global Transcatheter Mitral Valve Repair and Replacement Market is expected to grow as a result of continual technological developments such as the creation of multiple-use valves. Edwards Lifesciences, for example, received FDA approval in June 2017 for their SAPIEN 3 transcatheter prosthetic heart valve, which is approved for use in both mitral and aortic valves.


The number of TMVR pipeline devices used to treat mitral valve problems is predicted to rise, propelling the TMVR market forward. For example, a randomised clinical trial for the Medtronic Intrepid Transcatheter Mitral Valve Replacement System, sponsored by Medtronic Cardiovascular, is now underway and expected to conclude in October 2025.


Market Segmentation:

By Product Type

  • Bioprosthetic Tissue (Biological) Valves
  • Mechanical Valves

By Indication
  • Mitral Valve Regurgitation
  • Mitral Valve Stenosis
  • Mitral Valve Prolapse

By End User
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Cardiac Centers

North America is likely to dominate the transcatheter mitral valve repair and replacement sector due to the high prevalence of heart disease. Heart disease, for example, is the leading cause of death in the United States, with over 375,000 deaths per year. According to ClinicoEconomics and Outcomes Research 2016, mitral regurgitation is the most common valve disease in the United States, affecting nearly 1 in 10 persons aged 75 and over.


The key players operating in the global transcatheter mitral valve repair and replacement devices market include Abbott Laboratories, Biotronik Private Limited, Colibri Heart Valve, Edward Lifesciences Corporation, HLT Medical, LivaNova Plc, Medtronic Plc, Neovasc Inc., and NeoChord.

Comments

Popular posts from this blog

Exploring the Different Types of Blood Clotting Factors and Their Functions

Aromatherapy Market: A Scent-Sational Journey to Wellness and Market Growth

Molecular Sieves Catalyst Market: Global Company Analysis and Forecast 2018 – 2026 | Albemarle Corporation, W. R. Grace and Company, Silkem Ltd., Sinopec Group, and JGC Catalysts & Chemicals Ltd.